explore -WSS

explore

author：hotspot 2025-08-23 18:39:08 - browse：75268

A gene-edited Yucatan minipig. -- health coverage from STAT — A gene-edited Yucatan minipig created by eGenesis. Courtesy Liz Linder/eGenesis

For three days in December, an ICU room at the Hospital of the University of Pennsylvania bore witness to the first-ever merging of two powerful new technologies poised to change the future of transplant medicine.

On a gurney, a brain-dead patient lay connected to a whirring Rube Goldberg-esque machine: a tangle of tubes and siphons on wheels. From a cannula on one end, blood from the patient entered, was pumped full of oxygen and other nutrients, then pushed into a cozy, temperature-controlled chamber containing a liver — one that until very recently had belonged to a CRISPR-edited pig — before being returned to the patient.

The experiment, designed to test whether a genetically engineered porcine liver kept alive in a box could support the circulatory system of a human, was a resounding success, the research team said Thursday.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Activists slam private health insurers over coverage restrictions
Next article： Clinical trials giant ICON acquires HumanFirst

leisure time

WSS

How to fix the rural physician shortage in the U.S.

Kale crackers and hibiscus tea: My five days on a 'fasting diet'

ALS groups 'won't be played again' by the FDA, drug sponsors

Will General Catalyst be the first of many hospital takeovers?

Kenai launches with $82 million for Parkinson’s stem cell therapy

Diversify hospital leadership teams to protect BIPOC patient health

focus

explore

hotspot

Indiana Supreme Court upholds abortion ban, says state constitution gives only limited protections

Kristina Burow of ARCH Venture Partners shares her next big bets STAT

Trump demands the U.S. pay no more for drugs than other countries … again

Why getting cancer drugs just got harder for rural patients

Medicare proposal to cover medical devices draws a mixed reaction

Extreme heat events are a public health emergency

In Memoriam: Notable people who died in 2023

FogPharma raises $145 million in rare Series E round

Tori Bowie and the unacceptable rates of Black maternal death

Kenai launches with $82 million for Parkinson’s stem cell therapy

explore

Pfizer highlights cancer drugs it thinks could reignite investor interest

Free speech concerns arise in wake of journal editor Eisen's firing

FDA approves Recor Medical high blood pressure device

A Q&A with Aletha Maybank, AMA’s chief health equity officer

ALS groups 'won't be played again' by the FDA, drug sponsors

Why getting cancer drugs just got harder for rural patients

leisure time

focus

leisure time

focus